Janus Henderson Global Life Sciences Fund Class T (JAGLX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
80.73
-0.42 (-0.52%)
May 29, 2026, 4:00 PM EST
Fund Assets5.28B
Expense Ratio0.92%
Min. Investment$2,500
Turnover30.00%
Dividend (ttm)3.64
Dividend Yield4.49%
Dividend Growth-5.87%
Payout FrequencyAnnual
Ex-Dividend DateDec 5, 2025
Previous Close81.15
YTD Return0.36%
1-Year Return33.55%
5-Year Return50.13%
52-Week Low63.88
52-Week High84.43
Beta (5Y)0.61
Holdings104
Inception DateDec 31, 1998

About JAGLX

Janus Henderson Global Life Sciences Fund Class T is a mutual fund focused on the health sector, aiming to provide long-term capital growth. It invests primarily in companies with a life science orientation, seeking those that address unmet medical needs or enhance healthcare efficiency. The fund maintains a balanced portfolio across various sub-sectors, including biotechnology, healthcare services, medical devices, and pharmaceuticals. With a diversified approach across market capitalizations and geographies, it leverages the expertise of seasoned specialists to navigate the complex healthcare sector. By emphasizing growth potential and innovation, this fund plays a significant role in the financial market by capitalizing on advancements in healthcare technology and services.

Fund Family Janus Henderson
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol JAGLX
Share Class Class T
Index MSCI World/Health Care NR

Performance

JAGLX had a total return of 33.55% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.43%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
JFNNXClass N0.68%
JFNIXClass I0.77%
JNGLXClass D0.80%
JFNAXClass A0.98%

Top 10 Holdings

40.51% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY8.84%
Johnson & JohnsonJNJ7.29%
AstraZeneca PLCAZN4.59%
AbbVie Inc.ABBV4.05%
UnitedHealth Group IncorporatedUNH3.13%
Novartis AGNVS2.86%
Thermo Fisher Scientific Inc.TMO2.51%
Praxis Precision Medicines, Inc.PRAX2.45%
argenx SEARGX2.40%
Abbott LaboratoriesABT2.40%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 5, 2025$3.64134Dec 5, 2025
Dec 6, 2024$3.86839Dec 6, 2024
Dec 7, 2023$2.89991Dec 7, 2023
Dec 20, 2022$0.09366Dec 20, 2022
Dec 20, 2021$6.73381Dec 20, 2021
Dec 17, 2020$5.50316Dec 17, 2020
Full Dividend History